Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
13/26/13	NOK 0.3805	-1.68%	20,57,911
12/26/12	NOK 0.3870	-6.86%	44,35,721
11/26/11	NOK 0.4155	+8.49%	27,85,964
10/26/10	NOK 0.3830	-3.77%	22,25,854
09/26/09	NOK 0.3980	-2.09%	29,08,348

Real-time Oslo Bors

More quotes

EPS Estimates

Evolution of Analysts' Estimates - EPS - Lifecare ASA

Revisions to estimates

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Lifecare ASA

Company calendar

Market Closed - Oslo Bors 09:15:00 13/11/2026 pm IST			5-day change	1st Jan Change
0.3805 ^NOK	-1.68%		-6.40%	-88.33%

13/11	Lifecare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
12/11	Lifecare ASA, Q3 2026 Earnings Call, Nov 12, 2026

Market Cap	16Cr 1.62Cr 1.47Cr 1.36Cr 1.23Cr 2.31Cr 153.01Cr 2.39Cr 16Cr 6.48Cr 82Cr 6.09Cr 5.96Cr 259.45Cr	P/E 2026 *	-1.09x	P/E 2027 *	-2.38x
Enterprise Value	15Cr 1.53Cr 1.39Cr 1.28Cr 1.16Cr 2.18Cr 144.13Cr 2.26Cr 15Cr 6.1Cr 77Cr 5.74Cr 5.61Cr 244.4Cr	EV / Sales 2026 *	146x	EV / Sales 2027 *	-
Free-Float	69.99%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	LIFE	Real-time
CBOE		Real-time
Deutsche Boerse AG	LFC0	Delayed
Boerse Muenchen	LFC0	Real-time
Börse Stuttgart	LFC0	Delayed
CBOE		Real-time

13/11	Lifecare ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
12/11	Lifecare ASA, Q3 2026 Earnings Call, Nov 12, 2026
26/10	Lifecare ASA Advances Rapidly Towards Repeatable In-House Implant Manufacturing At New Bergen Facilities	CI
29/09	Lifecare Successfully Manufactures First Functional Implants In-House in Bergen	CI
14/09	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
11/09	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
31/08	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
19/08	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
19/08	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT
27/06	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
19/06	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news: Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Price Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

12/11	Lifecare : Interim Report Q3 2026	PU
12/11	Lifecare : Interim Report Q3 2026 Presentation	PU
30/09	Lifecare : Mandatory Notification of Trade by Primary Insider	PU
29/09	Lifecare successfully manufactures first functional implants in-house in Bergen	AQ
19/08	Lifecare : Interim Report Q2 2026 Presentation	PU

1 day	-1.68%
1 week	-6.40%
Current month	-12.73%
1 month	-14.30%
3 months	+18.91%
6 months	-4.64%
Current year	-88.33%

1 week	0.38	0.42
1 month	0.38	0.53
Current year	0.27	1.99
1 year	0.27	5.86
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-1.68%	-6.40%	-92.07%	-99.29%	1.62Cr
WUXI APPTEC CO., LTD.	-2.69%	-0.48%	+51.67%	+69.09%	6.63TCr
ARGENX SE	-0.92%	+7.67%	+14.26%	+90.92%	6.06TCr
LONZA GROUP AG	0.00%	+0.39%	+20.52%	+98.45%	5.55TCr
BEONE MEDICINES AG	+0.14%	+2.35%	+13.08%	+109.47%	4.76TCr
IQVIA HOLDINGS INC.	-2.21%	-2.47%	+18.60%	+36.89%	4.37TCr
REVOLUTION MEDICINES, INC.	-2.30%	-10.40%	+167.61%	+776.79%	3.73TCr
CELLTRION, INC.	+2.15%	+1.42%	+15.17%	+56.49%	3.66TCr
GENMAB A/S	-2.32%	-2.24%	+75.52%	+52.70%	3.22TCr
INSMED INCORPORATED	+2.62%	+5.90%	-36.55%	+406.95%	2.66TCr
Average	-0.72%	-0.60%	+24.78%	+159.85%	4TCr
Weighted average by Cap.	-0.83%	+0.20%	+37.22%	+162.18%

	2026 *	2027 *
Net sales	10L 1L 94.79T 87.68T 79.11T 1L 98.63L 2L 10.53L 4L 52.69L 4L 4L 1.67Cr	-
Net income	-11Cr -1.14Cr -1.03Cr -95.57L -86.23L -1.62Cr -107.51Cr -1.68Cr -11Cr -4.55Cr -57Cr -4.28Cr -4.19Cr -182.3Cr	-6.7Cr -70.09L -63.51L -58.74L -53L -99.88L -66Cr -1.03Cr -7.06Cr -2.8Cr -35Cr -2.63Cr -2.57Cr -112.05Cr
Net Debt	-90L -9L -9L -8L -7L -13.42L -8.88Cr -13.89L -94.79L -37.59L -4.74Cr -35.33L -34.58L -15Cr	40L 4L 4L 4L 3L 6L 3.95Cr 6L 42.13L 16.71L 2.11Cr 15.7L 15.37L 6.69Cr